Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability

Virology

Volumn 422, Issue 2, 2012, Pages 326-337

  Kelley, James F ^a   Kaufusi, Pakieli H ^a   Nerurkar, Vivek R ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Adhesion molecules; Chemokines and cytokines; Dengue virus; DENV; Flavivirus; Human microvascular endothelial cells (HMVEC); ICAM 1, VCAM 1, E selectin; Nonstructural 2KNS4B protein; TEER, FITC dextran; THP 1 monocytes; Transwell permeability model

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; NONSTRUCTURAL 2KNS4B PROTEIN; NONSTRUCTURAL 4B PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VIRUS PROTEIN;

ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENGUE; DENGUE VIRUS; HUMAN; HUMAN CELL; MATURATION; MICROVASCULAR ENDOTHELIAL CELL; MODULATION; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RNA VIRUS INFECTION; SUPERNATANT; THEORETICAL MODEL; THP 1 MONOCYTE; TRANSWELL PERMEABILITY MODEL;

ANIMALS; CELL ADHESION MOLECULES; CELL LINE; CELL SURVIVAL; CYTOKINES; DENGUE HEMORRHAGIC FEVER; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MONOCYTES; PERMEABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL NONSTRUCTURAL PROTEINS;

DENGUE VIRUS; FLAVIVIRUS;

EID: 84855206498     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.10.030     Document Type: Article

References (82)

1. Anderson R., Wang S., Osiowy C., Issekutz A.C. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J. Virol. 1997, 71(6):4226-4232.
2. Andrews B.S., Theofilopoulos A.N., Peters C.J., Loskutoff D.J., Brandt W.E., Dixon F.J. Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect. Immun. 1978, 20(3):776-781.
3. Arevalo M.T., Simpson-Haidaris P.J., Kou Z., Schlesinger J.J., Jin X. Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection. J. Med. Virol. 2009, 81(3):519-528.
4. Atrasheuskaya A., Petzelbauer P., Fredeking T.M., Ignatyev G. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol. Med. Microbiol. 2003, 35(1):33-42.
5. Avirutnan P., Malasit P., Seliger B., Bhakdi S., Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 1998, 161(11):6338-6346.
6. Bethell D.B., Flobbe K., Cao X.T., Day N.P., Pham T.P., Buurman W.A., Cardosa M.J., White N.J., Kwiatkowski D. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J. Infect. Dis. 1998, 177(3):778-782.
7. Beynon H.L., Haskard D.O., Davies K.A., Haroutunian R., Walport M.J. Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin. Exp. Immunol. 1993, 91(2):314-319.
8. Bhamarapravati N., Tuchinda P., Boonyapaknavik V. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann. Trop. Med. Parasitol. 1967, 61(4):500-510.
9. Biffl W.L., Moore E.E., Moore F.A., Carl V.S., Franciose R.J., Banerjee A. Interleukin-8 increases endothelial permeability independent of neutrophils. J. Trauma 1995, 39(1):98-102. (discussion 102-3).
10. Bonner S.M., O'Sullivan M.A. Endothelial cell monolayers as a model system to investigate dengue shock syndrome. J. Virol. Methods 1998, 71(2):159-167.
11. Bozza F.A., Cruz O.G., Zagne S.M., Azeredo E.L., Nogueira R.M., Assis E.F., Bozza P.T., Kubelka C.F. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect. Dis. 2008, 8:86.
12. Braga E.L., Moura P., Pinto L.M., Ignacio S.R., Oliveira M.J., Cordeiro M.T., Kubelka C.F. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Mem. Inst. Oswaldo Cruz 2001, 96(2):229-232.
13. Bunyaratvej A., Butthep P., Yoksan S., Bhamarapravati N. Dengue viruses induce cell proliferation and morphological changes of endothelial cells. Southeast Asian J. Trop. Med. Public Health 1997, 28(Suppl 3):32-37.
14. Burke-Gaffney A., Keenan A.K. Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1 alpha/beta, tumor necrosis factor-alpha and interferon-gamma. Immunopharmacology 1993, 25(1):1-9.
15. Cardier J.E., Marino E., Romano E., Taylor P., Liprandi F., Bosch N., Rothman A.L. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. Cytokine 2005, 30(6):359-365.
16. Carr J.M., Hocking H., Bunting K., Wright P.J., Davidson A., Gamble J., Burrell C.J., Li P. Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers. J. Med. Virol. 2003, 69(4):521-528.
17. Chakravarti A., Kumaria R. Circulating levels of tumour necrosis factor-alpha and interferon-gamma in patients with dengue and dengue haemorrhagic fever during an outbreak. Indian J. Med. Res. 2006, 123(1):25-30.
18. Chang C.S., Harn M.R., Nimmannitya S. Clinical observation of 15 Thai children with dengue hemorrhagic fever. Gaoxiong Yi Xue Ke Xue Za Zhi 1990, 6(3):131-136.
19. Chareonsirisuthigul T., Kalayanarooj S., Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J. Gen. Virol. 2007, 88(Pt 2):365-375.
20. Chen L.C., Shyu H.W., Lin H.M., Lei H.Y., Lin Y.S., Liu H.S., Yeh T.M. Dengue virus induces thrombomodulin expression in human endothelial cells and monocytes in vitro. J. Infect. 2009, 58(5):368-374.
21. Clark P.R., Manes T.D., Pober J.S., Kluger M.S. Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations. J. Invest. Dermatol. 2007, 127(4):762-774.
22. De Staercke C., Phillips D.J., Hooper W.C. Differential responses of human umbilical and coronary artery endothelial cells to apoptosis. Endothelium 2003, 10(2):71-78.
23. Detmar M., Tenorio S., Hettmannsperger U., Ruszczak Z., Orfanos C.E. Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J. Invest. Dermatol. 1992, 98(2):147-153.
24. Dewi B.E., Takasaki T., Kurane I. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J. Virol. Methods 2004, 121(2):171-180.
25. Dewi B.E., Takasaki T., Kurane I. Peripheral blood mononuclear cells increase the permeability of dengue virus-infected endothelial cells in association with downregulation of vascular endothelial cadherin. J. Gen. Virol. 2008, 89(Pt 3):642-652.
26. Dhawan S., Singh S., Aggarwal B.B. Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B. Eur. J. Immunol. 1997, 27(9):2172-2179.
27. Durbin A.P., Vargas M.J., Wanionek K., Hammond S.N., Gordon A., Rocha C., Balmaseda A., Harris E. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 2008, 376(2):429-435.
28. Elherik K.E., Khan F., Belch J.J. Differences in endothelial function and vascular reactivity between Scottish and Arabic populations. Scott. Med. J. 2003, 48(3):85-87.
29. Feldmann H., Bugany H., Mahner F., Klenk H.D., Drenckhahn D., Schnittler H.J. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J. Virol. 1996, 70(4):2208-2214.
30. Fisher-Hoch S.P., Platt G.S., Neild G.H., Southee T., Baskerville A., Raymond R.T., Lloyd G., Simpson D.I. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J. Infect. Dis. 1985, 152(5):887-894.
31. Gerritsen M.E., Niedbala M.J., Szczepanski A., Carley W.W. Cytokine activation of human macro- and microvessel-derived endothelial cells. Blood Cells 1993, 19(2):325-339. (discussion 340-2).
32. Gibbs L.S., Lai L., Malik A.B. Tumor necrosis factor enhances the neutrophil-dependent increase in endothelial permeability. J. Cell. Physiol. 1990, 145(3):496-500.
33. Halstead S.B. Pathogenesis of dengue: challenges to molecular biology. Science 1988, 239(4839):476-481.
34. Halstead S.B. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 1989, 11(Suppl. 4):S830-S839.
35. Huang Y.H., Lei H.Y., Liu H.S., Lin Y.S., Liu C.C., Yeh T.M. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am. J. Trop. Med. Hyg. 2000, 63(1-2):71-75.
36. Iyngkaran N., Yadav M., Sinniah M. Augmented inflammatory cytokines in primary dengue infection progressing to shock. Singapore Med. J. 1995, 36(2):218-221.
37. Jacobs M., Levin M. An improved endothelial barrier model to investigate dengue haemorrhagic fever. J. Virol. Methods 2002, 104(2):173-185.
38. Jessie K., Fong M.Y., Devi S., Lam S.K., Wong K.T. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J. Infect. Dis. 2004, 189(8):1411-1418.
39. Kanlaya R., Pattanakitsakul S.N., Sinchaikul S., Chen S.T., Thongboonkerd V. Alterations in actin cytoskeletal assembly and junctional protein complexes in human endothelial cells induced by dengue virus infection and mimicry of leukocyte transendothelial migration. J. Proteome Res. 2009, 8(5):2551-2562.
40. Kelley J.F., Kaufusi P.H., Volper E.M., Nerurkar V.R. Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines. Virology 2011, 418(1):27-39.
41. Khongphatthanayothin A., Phumaphuti P., Thongchaiprasit K., Poovorawan Y. Serum levels of sICAM-1 and sE-selectin in patients with dengue virus infection. Jpn. J. Infect. Dis. 2006, 59(3):186-188.
42. Koraka P., Murgue B., Deparis X., Van Gorp E.C., Setiati T.E., Osterhaus A.D., Groen J. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J. Med. Virol. 2004, 72(3):445-450.
43. Kuno G., Bailey R.E. Cytokine responses to dengue infection among Puerto Rican patients. Mem. Inst. Oswaldo Cruz 1994, 89(2):179-182.
44. Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp. Immunol. Microbiol. Infect. Dis. 2007, 30(5-6):329-340.
45. Kurane I., Takasaki T. Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large. Rev. Med. Virol. 2001, 11(5):301-311.
46. Kurane I., Rothman A.L., Livingston P.G., Green S., Gagnon S.J., Janus J., Innis B.L., Nimmannitya S., Nisalak A., Ennis F.A. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. Suppl. 1994, 9:59-64.
47. Lambeth C.R., White L.J., Johnston R.E., de Silva A.M. Flow cytometry-based assay for titrating dengue virus. J. Clin. Microbiol. 2005, 43(7):3267-3272.
48. Lee Y.R., Liu M.T., Lei H.Y., Liu C.C., Wu J.M., Tung Y.C., Lin Y.S., Yeh T.M., Chen S.H., Liu H.S. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J. Gen. Virol. 2006, 87(Pt 12):3623-3630.
49. Lefer A.M. Significance of lipid mediators in shock states. Circ. Shock 1989, 27(1):3-12.
50. Leong A.S., Wong K.T., Leong T.Y., Tan P.H., Wannakrairot P. The pathology of dengue hemorrhagic fever. Semin. Diagn. Pathol. 2007, 24(4):227-236.
51. Libraty D.H., Endy T.P., Houng H.S., Green S., Kalayanarooj S., Suntayakorn S., Chansiriwongs W., Vaughn D.W., Nisalak A., Ennis F.A., Rothman A.L. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J. Infect. Dis. 2002, 185(9):1213-1221.
52. Luhtala N., Parker R. LSM1 over-expression in Saccharomyces cerevisiae depletes U6 snRNA levels. Nucleic Acids Res. 2009, 37(16):5529-5536.
53. Malavige G.N., Fernando S., Fernando D.J., Seneviratne S.L. Dengue viral infections. Postgrad. Med. J. 2004, 80(948):588-601.
54. Marcus B.C., Wyble C.W., Hynes K.L., Gewertz B.L. Cytokine-induced increases in endothelial permeability occur after adhesion molecule expression. Surgery 1996, 120(2):411-416. (discussion 416-7).
55. Medin C.L., Fitzgerald K.A., Rothman A.L. Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J. Virol. 2005, 79(17):11053-11061.
56. Molet S., Gosset P., Vanhee D., Tillie-Leblond I., Wallaert B., Capron M., Tonnel A.B. Modulation of cell adhesion molecules on human endothelial cells by eosinophil-derived mediators. J. Leukoc. Biol. 1998, 63(3):351-358.
57. Murgue B. Severe dengue: questioning the paradigm. Microbes Infect. 2010, 12(2):113-118.
58. Nguyen T.H., Lei H.Y., Nguyen T.L., Lin Y.S., Huang K.J., Le B.L., Lin C.F., Yeh T.M., Do Q.H., Vu T.Q., Chen L.C., Huang J.H., Lam T.M., Liu C.C., Halstead S.B. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 2004, 189(2):221-232.
59. Nooteboom A., Hendriks T., Otteholler I., van der Linden C.J. Permeability characteristics of human endothelial monolayers seeded on different extracellular matrix proteins. Mediators Inflamm. 2000, 9(5):235-241.
60. Petreaca M.L., Yao M., Liu Y., Defea K., Martins-Green M. Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability. Mol. Biol. Cell 2007, 18(12):5014-5023.
61. Pober J.S., Cotran R.S. Cytokines and endothelial cell biology. Physiol. Rev. 1990, 70(2):427-451.
62. Priyadarshini D., Gadia R.R., Tripathy A., Gurukumar K.R., Bhagat A., Patwardhan S., Mokashi N., Vaidya D., Shah P.S., Cecilia D. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One 2010, 5(1):e8709.
63. Raghupathy R., Chaturvedi U.C., Al-Sayer H., Elbishbishi E.A., Agarwal R., Nagar R., Kapoor S., Misra A., Mathur A., Nusrat H., Azizieh F., Khan M.A., Mustafa A.S. Elevated levels of IL-8 in dengue hemorrhagic fever. J. Med. Virol. 1998, 56(3):280-285.
64. Sahaphong S., Riengrojpitak S., Bhamarapravati N., Chirachariyavej T. Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. Southeast Asian J. Trop. Med. Public Health 1980, 11(2):194-204.
65. Salvaggio M.R., Baddley J.W. Other viral bioweapons: Ebola and Marburg hemorrhagic fever. Dermatol. Clin. 2004, 22(3):291-302. (vi).
66. Shresta S., Sharar K.L., Prigozhin D.M., Snider H.M., Beatty P.R., Harris E. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J. Immunol. 2005, 175(6):3946-3954.
67. Srichaikul T., Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract. Res. Clin. Haematol. 2000, 13(2):261-276.
68. Srikiatkhachorn A. Plasma leakage in dengue haemorrhagic fever. Thromb. Haemost. 2009, 102(6):1042-1049.
69. Sumagin R., Lomakina E., Sarelius I.H. Leukocyte-endothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling. Am. J. Physiol. Heart Circ. Physiol. 2008, 295(3):H969-H977.
70. Talavera D., Castillo A.M., Dominguez M.C., Gutierrez A.E., Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J. Gen. Virol. 2004, 85(Pt 7):1801-1813.
71. Tan G.K., Ng J.K., Trasti S.L., Schul W., Yip G., Alonso S. A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. PLoS Negl. Trop. Dis. 2010, 4(4):e672.
72. Ubol S., Chareonsirisuthigul T., Kasisith J., Klungthong C. Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells. Virology 2008, 376(2):290-296.
73. Vaughan G., Gonzalez-Hernandez Y., Gudino J.C., Olivera H., Landa-Piedra A., Escobar-Gutierrez A. An alternative method for the synthesis of competitor RNA transcripts useful for specific detection and quantitation of dengue virus serotype 2 genome and replicative intermediate RNA. J. Virol. Methods 2008, 152(1-2):72-76.
74. Verma S., Ziegler K., Ananthula P., Co J.K., Frisque R.J., Yanagihara R., Nerurkar V.R. JC virus induces altered patterns of cellular gene expression: interferon-inducible genes as major transcriptional targets. Virology 2006, 345(2):457-467.
75. Verma S., Molina Y., Lo Y.Y., Cropp B., Nakano C., Yanagihara R., Nerurkar V.R. In vitro effects of selenium deficiency on West Nile virus replication and cytopathogenicity. Virol. J. 2008, 5:66.
76. Verma S., Lo Y., Chapagain M., Lum S., Kumar M., Gurjav U., Luo H., Nakatsuka A., Nerurkar V.R. West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the in vitro blood-brain barrier. Virology 2009, 385(2):425-433.
77. Vitarana T., de Silva H., Withana N., Gunasekera C. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Med. J. 1991, 36(2):63-65.
78. Warke R.V., Xhaja K., Martin K.J., Fournier M.F., Shaw S.K., Brizuela N., de Bosch N., Lapointe D., Ennis F.A., Rothman A.L., Bosch I. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J. Virol. 2003, 77(21):11822-11832.
79. WHO Dengue Haemorrhagic Fever: Diagnosis, Treatment Prevention and Control 1997, WHO, Geneva.
80. World Health Organization Dengue Haemorrhagic Fever: Diagnosis, Treatment Prevention and Control 1997, WHO, Geneva.
81. World Health Organization Dengue and dengue haemorrhagic fever 2009, (Fact sheet #117 ed.), WHO Media Centre, Geneva.
82. Wyble C.W., Desai T.R., Clark E.T., Hynes K.L., Gewertz B.L. Physiologic concentrations of TNFalpha and IL-1beta released from reperfused human intestine upregulate E-selectin and ICAM-1. J. Surg. Res. 1996, 63(1):333-338.